UI Hospitals and Clinics
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma - A Phase III, Double Randomized Trial (ACNS0331)
The main purpose of this study is to find out if reducing the overall dose of radiation to the brain and spine will reduce rates of survival in children with medulloblastoma. The study will also look at whether reducing the volume of radiation given during the boost will reduce survival rates in children with medulloblastoma.
Victoria Scaccia, 319-356-7875
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.